These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2404388)
41. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet; 1988 Aug; 2(8607):349-60. PubMed ID: 2899772 [TBL] [Abstract][Full Text] [Related]
42. [A european multicenter and randomized study of APSAC versus streptokinase in myocardial infarction]. Charbonnier B; Cribier A; Monassier JP; Favier JP; Materne P; Brochier ML; Letac B; Hanssen M; Sacrez A; Kulbertus H Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1565-71. PubMed ID: 2510677 [TBL] [Abstract][Full Text] [Related]
43. Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. ESCALAT Investigators. Fung AY; Lorch G; Cambier PA; Hansen D; Titus BG; Martin JS; Lee JJ; Every NR; Hallstrom AP; Stock-Novack D; Scherer J; Weaver WD Am Heart J; 1999 Oct; 138(4 Pt 1):696-704. PubMed ID: 10502216 [TBL] [Abstract][Full Text] [Related]
44. Intravenous streptokinase in acute myocardial infarction. Mayer G; Story WE; Seco JE; Nocero MA; Shaskey DJ; Black MA Ann Emerg Med; 1985 May; 14(5):410-5. PubMed ID: 3985460 [TBL] [Abstract][Full Text] [Related]
45. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. Ribeiro EE; Silva LA; Carneiro R; D'Oliveira LG; Gasquez A; Amino JG; Tavares JR; Petrizzo A; Torossian S; Duprat Filho R J Am Coll Cardiol; 1993 Aug; 22(2):376-80. PubMed ID: 8335807 [TBL] [Abstract][Full Text] [Related]
46. Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: the COMPASS Equivalence Trial. Comparison Trial of Saruplase and Streptokinase (COMASS) Investigators. Tebbe U; Michels R; Adgey J; Boland J; Caspi A; Charbonnier B; Windeler J; Barth H; Groves R; Hopkins GR; Fennell W; Betriu A; Ruda M; Mlczoch J J Am Coll Cardiol; 1998 Mar; 31(3):487-93. PubMed ID: 9502624 [TBL] [Abstract][Full Text] [Related]
47. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Schröder R; Biamino G; von Leitner ER; Linderer T; Brüggemann T; Heitz J; Vöhringer HF; Wegscheider K Circulation; 1983 Mar; 67(3):536-48. PubMed ID: 6821895 [TBL] [Abstract][Full Text] [Related]
48. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator]. Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348 [TBL] [Abstract][Full Text] [Related]
49. Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial. Rentrop KP; Feit F; Sherman W; Thornton JC Circulation; 1989 Nov; 80(5):1166-75. PubMed ID: 2509103 [TBL] [Abstract][Full Text] [Related]
50. Limitation of myocardial infarct size and preservation of left ventricular function by early administration of APSAC in myocardial infarction. Bassand JP; Machecourt J; Cassagnes J; Lusson JR; Borel E; Schiele F Am J Cardiol; 1989 Jul; 64(2):18A-23A; discussion 24A-26A. PubMed ID: 2662738 [TBL] [Abstract][Full Text] [Related]
51. [Effect of intracoronary streptokinase infusion and verapamil treatment on the size of the affected area in myocardial infarct patients]. Vasil'tsev IaS; Karpov RS; Markov VA; Varvarenko VI; Kun VI Kardiologiia; 1986 Aug; 26(8):58-63. PubMed ID: 3761850 [TBL] [Abstract][Full Text] [Related]
52. Intravenous streptokinase in acute myocardial infarction (I.S.A.M.) trial: serial evaluation of left ventricular function up to 3 years after infarction estimated by radionuclide ventriculography. I.S.A.M. Study Group. Voth E; Tebbe U; Schicha H; Neuhaus KL; Schröder R J Am Coll Cardiol; 1991 Dec; 18(7):1610-6. PubMed ID: 1960304 [TBL] [Abstract][Full Text] [Related]
53. [Intravenous streptokinase infusions in acute myocardial infarction. Restoring patency of occluded thrombotic coronary vessels (author's transl)]. Schröder R; Biamino G; von Leitner ER; Linderer T Dtsch Med Wochenschr; 1981 Mar; 106(10):294-301. PubMed ID: 7472157 [TBL] [Abstract][Full Text] [Related]
54. Intravenous fibrinolytic therapy of acute myocardial infarction: new perspectives from plasminogen activators? Kasper W; Meinertz T; Just H Klin Wochenschr; 1986 Apr; 64(7):301-6. PubMed ID: 3086619 [TBL] [Abstract][Full Text] [Related]
55. Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Kasper W; Meinertz T; Wollschläger H; Bonzel T; Chen C; Hofmann T; Zeiher A; Drexler H; Just H Drugs; 1987; 33 Suppl 3():112-6. PubMed ID: 3315575 [TBL] [Abstract][Full Text] [Related]
56. Rapid lysis of coronary artery thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection. Marder VJ; Rothbard RL; Fitzpatrick PG; Francis CW Ann Intern Med; 1986 Mar; 104(3):304-10. PubMed ID: 3511819 [TBL] [Abstract][Full Text] [Related]
57. Intravenous streptokinase in acute evolving myocardial infarction--six to thirty-six months follow up. Chopra KL; Chopra HK; Aggarwal KK Indian Heart J; 1990; 42(1):13-25. PubMed ID: 2190912 [TBL] [Abstract][Full Text] [Related]
58. [Long-term follow-up of acute myocardial infarction after early intravenous streptokinase]. Gurevitch J; Mosseri M; Lotan C; Sapoznikov D; Gotsman MS Harefuah; 1989 Jan; 116(1):6-11. PubMed ID: 2707666 [TBL] [Abstract][Full Text] [Related]
59. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lancet; 1990 Jul; 336(8707):65-71. PubMed ID: 1975321 [TBL] [Abstract][Full Text] [Related]
60. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC). Johnson ES; Cregeen RJ Drugs; 1987; 33 Suppl 3():298-311. PubMed ID: 3315612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]